The impact of obstructive sleep apnea and nasal CPAP on circulating adiponectin levels

Lung

Volumn 192, Issue 2, 2014, Pages 289-295

  Yoshikawa, Masanori ^a   Yamauchi, Motoo ^a   Fujita, Yukio ^a   Koyama, Noriko ^a   Fukuoka, Atsuhiko ^a   Tamaki, Shinji ^a   Yamamoto, Yoshifumi ^a   Tomoda, Koichi ^a   Kimura, Hiroshi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Adiponectin; Atherosclerosis; Nasal continuous positive airway pressure; Obstructive sleep apnea syndrome; Soluble intercellular adhesion molecule 1; Tumor necrosis factor

Indexed keywords

ADIPONECTIN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; APNEA HYPOPNEA INDEX; ARTICLE; BODY MASS; CLINICAL ARTICLE; HUMAN; HYPOTHESIS; HYPOXIA; MALE; MIDDLE AGED; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP DISORDERED BREATHING;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTINUOUS POSITIVE AIRWAY PRESSURE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; SLEEP APNEA, OBSTRUCTIVE; TIME FACTORS; TREATMENT OUTCOME; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84897051867     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9550-9     Document Type: Article

References (36)

1. Shinohara E, Kihara S, Yamashita S, Yamane M, Nishida M, Arai T, Kotani K, Nakamura T, Takemura K, Matsuzawa Y (1997) Visceral fat accumulation as an important risk factor for obstructive sleep apnoea syndrome in obese subjects. J Intern Med 241:11-18 (Pubitemid 27051198)
2. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (adipose most abundant gene transcript 1). Biochem Biophys Res Commun 221:286-289 (Pubitemid 26136463)
3. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, Matsuzawa Y (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79-83 (Pubitemid 29299050)
4. Suzuki T, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Yamauchi M, Kimura H (2004) Obstructive sleep apnea and carotid artery intima-media thickness. Sleep 27:129-133 (Pubitemid 43906324)
5. Marin JM, Carrizo SJ, Vicente E, Agusti AGN (2005) Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053 (Pubitemid 40386782)
6. Rossa R (1999) Atherosclerosis: an inflammatory disease. N Engl J Med 340:115-126
7. Tamaki S, Yamauchi M, Fukuoka A, Makinodan K, Koyama N, Tomoda K, Yoshikawa M, Kimura H (2009) Nocturnal hypoxic stress activates invasive ability of monocytes in patients with obstructive sleep apnea syndrome. Respirology 14:689-694
8. Ridker PM, Hennekens CH, Roitman-Johnson B, Stampfer MJ, Allen J (1998) Plasma concentration of soluble intercellular adhesion molecule-1 and risks of future myocardial infarction in apparently healthy men. Lancet 351:88-92 (Pubitemid 28026634)
9. Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, Hotta K, Nishida M, Takahashi M, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (1999) Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation 100:2473-2476 (Pubitemid 30005109)
10. Albelda SM, Smith CW, Ward PA (1994) Adhesion molecules and inflammatory injury. FASEB J 8:504-512 (Pubitemid 24161123)
11. Ohga E, Nagase T, Tomita T, Teramoto S, Matsuse T, Katayama H, Ouchi Y (1999) Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. J Appl Physiol 87:10-14 (Pubitemid 29330658)
12. El-Solh AA, Mador MJ, Sikka P, Dhillon RS, Amsterdam D, Grant BJ (2002) Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest 121:1541-1547 (Pubitemid 34499668)
13. Ursavaş A, Karadaǧ M, Rodoplu E, Yilmaztepe A, Oral HB, Gözü RO (2007) Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration 74:525-532
14. Dekker JM, Funahashi T, Nijpels G, Pilz S, Stehouwer CDA, Snijder MB, Bouter LM, Matsuzawa Y, Shimomura I, Heine RJ (2008) Prognostic value of adiponectin for cardiovascular disease and mortality. J Clin Endocrin Metab 93:1489-1496 (Pubitemid 351519753)
15. Zhang XL, Yin KS, Wang H, Su S (2006) Serum adiponectin levels in adult male patients with obstructive sleep apnea syndrome. Respiration 73:73-77
16. Masserini B, Morpurgo PS, Donadio F, Bardessari C, Bossi R, Beck-Peccoz P, Orsi E (2006) Reduced levels of adiponectin in sleep apnea syndrome. J Endcrinol Invest 29:700-705 (Pubitemid 44756174)
17. Nakagawa Y, Kishida K, Kihara S, Sonoda M, Hirata A, Yasui A, Nishizawa H, Nakamura T, Yoshida R, Shimomura I, Funahashi T (2008) Nocturnal reduction in circulating adiponectin concentrations related to hypoxic stress in severe obstructive sleep apnea-hypopnea syndrome. Am J Physiol Endocrinol Metab 294:E778-E784 (Pubitemid 351483603)
18. Kim J, Lee CH, Park CS, Kim BG, Kim SW, Cho JH (2010) Plasma levels of MCP-1 and adiponectin in obstructive sleep apnea syndrome. Arch Otolaryngol Head Neck Surg 136:896-899
19. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12-17 (Pubitemid 46044133)
20. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, Somers VK (2005) Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13:186-190
21. Tokuda F, Sando Y, Matsui H, Koike H, Yokoyama T (2008) Serum levels of adiponectin and leptin, in patients with obstructive sleep apnea. Intern Med 47:1843-1849
22. Sánchez-de-la-Torre M, Mediano O, Barceló A, Piérola J, de la Peña M, Esquinas C, Miro A, Durán-Cantolla J, Agustí AG, Capote F, Marin JM, Montserrat JM, García-Río F, Barbé F (2012) The influence of obesity and obstructive sleep apnea on metabolic hormones. Sleep Breath 16:649-656
23. Makino S, Handa H, Suzukawa K, Fujiwara M, Nakamura M, Muraoka S, Takasago I, Tanaka Y, Hashimoto K, Sugimoto T (2006) Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol 64:12-19
24. Harsch IA, Wallaschofski H, Koebnik C, PourSchahin S, Hahn EG, Ficker JH, Lohmann T (2004) Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71:580-586 (Pubitemid 40091430)
25. Hosogai N, Fukuhara A, Oshima K, Miyata Y, Tanaka S, Segawa K, Furukawa S, Tochino Y, Komuro R, Matsuda M, Shimomura I (2007) Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 56:901-911 (Pubitemid 46525054)
26. Yamauchi M, Tamaki S, Tomoda K, Yoshikawa M, Fukuoka A, Makinodan K, Koyama N, Suzuki T, Kimura H (2006) Evidence of activation of nuclear factor kappaB in obstructive sleep apnea. Sleep Breath 10:189-193 (Pubitemid 44768845)
27. Ridker PM, Rifai N, Pfeffer M, Sacks F, Lepage S, Braunwald E (2000) Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction. Circulation 101:2149-2153 (Pubitemid 30253042)
28. Minoguchi K, Tazaki T, Yokoe T, Minoguchi H, Watanabe Y, Yamamoto M, Adachi M (2004) Elevated production of tumor necrosis factor-alpha by monocytes in patients with obstructive sleep apnea syndrome. Chest 126:1473-1479 (Pubitemid 39525019)
29. Ryan S, Taylor CT, McNichols WT (2005) Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 112:2660-2667 (Pubitemid 41532603)
30. Chin K, Nakamura T, Shimizu K, Mishima M, Nakamura T, Miyasaka M, Ohi M (2000) Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med 109:562-567
31. Zamarron C, Riveiro A, Gude F (2011) Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Arch Med Sci 6:1023-1028
32. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H, Hotta K, Nishida M, Takahashi M, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Funahashi T, Matsuzawa Y (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κB signaling through a cAMP-dependent pathway. Circulation 102:1296-1301
33. Maeda N, Shimonura I, Kishida K, Kishida K, Nishizawa H, Matsuda M, Nagaretani H, Furuyama N, Kondo H, Takahashi M, Arita Y, Komuro R, Ouchi N, Kihara S, Tochino Y, Okutomi K, Horie M, Takeda S, Aoyama T, Funahashi T, Matsuzawa Y (2002) Diet-induced insulin resistance in mice lacking adiponectin/ACRP30. Nat Med 8:731-737 (Pubitemid 34778727)
34. Bemelmans MH, van Tits LJ, Buurman WA (1996) Tumor necrosis factor: function, release and clearance. Crit Rev Immunol 16:1-11 (Pubitemid 26239999)
35. Arberti A, Sarchielli P, Gallinella E, Floridi A, Floridi A, Mazzotta G, Gallai V (2003) Plasma cytokine levels in patients with obstructive sleep apnea syndrome: a preliminary study. J Sleep Res 12:305-311 (Pubitemid 38010437)
36. Vgontzas AN, Zoumakis E, Lin HM, Bixler EO, Trakada G, Chrousos GP (2004) Marked decrease in sleepiness in patients with sleep apnea by etanercept, a tumor necrosis factor-a antagonist. J Clin Endocrinol Metab 89:4409-4413 (Pubitemid 39244447)